Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda.
Guay, Laura A; Musoke, Philippa; Hom, David L; Nakabiito, Clemensia; Bagenda, Danstan; Fletcher, Courtney V; Marum, Lawrence H; Fowler, Mary Glenn; Falksveden, Lars G; Wahren, Britta; Kataaha, Peter; Wigzell, Hans; Mmiro, Francis A; Jackson, J Brooks.
; 16(10): 1391-400, 2002 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-12131216
Structural insights on the role of antibodies in HIV-1 vaccine and therapy.
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
Playing Chess with HIV.
HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.
Bispecific Antibodies Against HIV.
The role of antibodies in HIV vaccines.
HIV Immunogens: Affinity Is Key.
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
Antibodies pose a double threat to HIV.